MILIC, Jovana
 Distribuzione geografica
Continente #
NA - Nord America 6.283
EU - Europa 3.634
AS - Asia 3.443
SA - Sud America 416
AF - Africa 129
Continente sconosciuto - Info sul continente non disponibili 128
OC - Oceania 34
Totale 14.067
Nazione #
US - Stati Uniti d'America 6.017
IT - Italia 1.469
SG - Singapore 1.044
CN - Cina 787
GB - Regno Unito 509
HK - Hong Kong 390
VN - Vietnam 340
SE - Svezia 305
BR - Brasile 301
DE - Germania 243
FI - Finlandia 213
BD - Bangladesh 208
RU - Federazione Russa 189
CA - Canada 187
FR - Francia 182
IN - India 114
KR - Corea 114
NL - Olanda 76
ES - Italia 70
ID - Indonesia 70
JP - Giappone 56
MX - Messico 47
ZA - Sudafrica 44
AR - Argentina 42
BG - Bulgaria 42
TR - Turchia 41
CH - Svizzera 39
IQ - Iraq 39
SI - Slovenia 38
AE - Emirati Arabi Uniti 31
BE - Belgio 30
IE - Irlanda 29
UA - Ucraina 29
AU - Australia 28
IR - Iran 28
PK - Pakistan 28
PL - Polonia 25
LT - Lituania 23
PH - Filippine 23
RO - Romania 22
SA - Arabia Saudita 22
UG - Uganda 22
CO - Colombia 20
MY - Malesia 18
EG - Egitto 15
TW - Taiwan 15
RS - Serbia 14
CL - Cile 13
EC - Ecuador 13
VE - Venezuela 13
NO - Norvegia 12
GR - Grecia 11
IL - Israele 11
UZ - Uzbekistan 11
AT - Austria 10
AZ - Azerbaigian 9
MA - Marocco 9
CZ - Repubblica Ceca 8
KE - Kenya 8
LB - Libano 7
AL - Albania 6
DO - Repubblica Dominicana 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
PE - Perù 6
TN - Tunisia 6
ET - Etiopia 5
HN - Honduras 5
HR - Croazia 5
JM - Giamaica 5
KG - Kirghizistan 5
PT - Portogallo 5
CR - Costa Rica 4
GE - Georgia 4
HU - Ungheria 4
NP - Nepal 4
PY - Paraguay 4
BY - Bielorussia 3
CG - Congo 3
DK - Danimarca 3
DZ - Algeria 3
JO - Giordania 3
LU - Lussemburgo 3
MK - Macedonia 3
NG - Nigeria 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
GH - Ghana 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
MC - Monaco 2
MD - Moldavia 2
Totale 13.914
Città #
Ashburn 712
Singapore 670
Santa Clara 668
Chandler 443
Fairfield 431
Hong Kong 359
San Jose 321
Hefei 253
Woodbridge 228
Nyköping 219
Helsinki 195
Seattle 177
Southend 171
London 161
Council Bluffs 159
Houston 155
Cambridge 151
New York 147
Wilmington 130
Modena 129
Beijing 124
Milan 123
Dallas 119
Ho Chi Minh City 116
Los Angeles 115
Rome 108
Seoul 98
Bologna 87
The Dalles 83
Hanoi 79
Chicago 73
Lauterbourg 60
San Diego 56
Ann Arbor 55
Jakarta 53
Toronto 52
Frankfurt am Main 48
Munich 48
Shanghai 47
Buffalo 46
Dearborn 44
Tokyo 40
Moscow 39
Princeton 39
Sofia 39
North York 38
São Paulo 36
St. Petersburg 35
Boardman 34
Montreal 30
Bremen 28
Amsterdam 27
Dublin 26
Florence 26
Zarautz 26
Brussels 25
Orem 25
Jacksonville 24
Salt Lake City 24
Phoenix 23
Atlanta 22
Denver 22
Roncoferraro 22
Naples 21
Piacenza 21
Kampala 20
Vinovo 20
Chennai 19
Düsseldorf 18
Nuremberg 18
Portsmouth 18
Brooklyn 17
Cape Town 17
Dammam 17
Redwood City 17
Sydney 17
Bucharest 16
Eugene 16
Mexico City 16
Parma 16
Stockholm 16
Kent 15
Perugia 15
Warsaw 15
Baghdad 14
Beauharnois 14
Isfahan 14
Poplar 14
Secaucus 14
Birmingham 13
Johannesburg 13
Paris 13
Redondo Beach 13
Tampa 13
Haiphong 12
Monza 12
Seriate 12
Da Nang 11
Dong Ket 11
Dubai 11
Totale 8.732
Nome #
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 518
Data-driven vs knowledge-driven inference of health outcomes in the ageing population: A case study 459
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 440
La sarcopenia nell’anziano con HIV 432
Voice assistance to develop a participatory research and action to improve health trajectories of people with PACS 374
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 367
Machine learning algorithm to predict weight change in ART experienced PWH 357
Decay pattern of anti–SARS–CoV–2 antibodies in PWH 341
Changes in central adipose tissue after switching to integrase inhibitors 334
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 332
Thymus Imaging Detection and Size Is Inversely Associated With Metabolic Syndrome and Frailty in People With HIV 327
The interplay between frailty and intrinsic capacity in aging and HIV infection 321
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia 321
Non–alcoholic to metabolic associated fatty liver disease: cardiovascular implications of a change in terminology in patients living with HIV 319
The pathway of NAFLD vs MAFLD toward significant fibrosis 314
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 310
Predicting Respiratory Failure in Patients with COVID-19 pneumonia: a case study from Northern Italy 298
Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV 295
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 283
Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients 269
From NAFLD to MAFLD: implications of change in terminology in PWH 261
The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV 261
Machine learning algorithm to predict >5% weight gain in PWH switching to INSTI 259
What is the measure of success in HIV? The fourth 90: quality of life or healthy aging? 258
Age of HIV Acquisition Affects the Risk of Multi-Morbidity after 25 Years of Infection Exposure 249
Managing antiretroviral therapy in the elderly HIV patient 244
The Interplay Between Age and Frailty in People Living With HIV: Results From an 11-Year Follow-up Observational Study 232
Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era 230
A patient-centred approach to deprescribing antiretroviral therapy in people living with HIV 229
Machine learning algorithm to predict >5% Weight Gain in PWH switching to InSTI 227
Non-alcoholic to metabolic associated fatty liver disease: Cardiovascular implications of a change in terminology in patients living with HIV 226
Sex Differences in People Aging With HIV 225
Relazioni chiave tra steatosi epatica, insulino-resistenza, diabete mellito, fragilità, terapia antiretrovirale basata sugli inibitori dell'integrasi e aumento di peso nelle persone che vivono con HIV 225
Aging with HIV 220
Relationship between weight gain and insulin resistance in people living with HIV switching to INSTI-based regimens 210
Characteristics of long COVID among older adults: a cross-sectional study 207
Dolutegravir is not associated with weight gain in ART experienced geriatric patients living with HIV 201
From NAFLD to MAFLD: implications of change in terminology in PWH 198
Resilience and Frailty in People Living With HIV During the COVID Era: Two Complementary Constructs Associated With Health-Related Quality of Life 193
The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected Persons 192
The pathway of NAFLD vs MAFLD toward significant fibrosis 190
Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus 187
AKI in hospitalized patients with COVID-19: a single-center experience 186
Impact of prolonged maraviroc treatment on non-AIDS-related comorbidities in HIV-positive patients: a retrospective cohort study 180
Diagnosis of liver fibrosis in ageing patients with HIV at risk for non-alcoholic fatty liver disease in Italy and Canada: assessment of a two-tier pathway 162
Why am I getting fat? Exploring immune-metabolic pathways to central fat accumulation in persons with HIV 145
Primary, secondary and compensated male biochemical hypogonadism in people living with HIV (PLWH): relevance of sex hormone-binding globulin (SHBG) measurement and comparison between liquid chromatography-tandem mass spectrometry (LC-MS/MS) and chemiluminescent immunoassay for sex steroids assay 145
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda 142
Vitamin e as a 'bridge' therapy for nonalcoholic steatohepatits in HIV: What is waiting on the other side of the bridge? 136
Tocilizumab for severe COVID-19 pneumonia – Authors' reply 131
A Metabolic Health Framework to Interpret Weight Gain Studies in People With Human Immunodeficiency Virus 121
Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia 116
Two-Tier Care Pathways for Liver Fibrosis Associated to Non-Alcoholic Fatty Liver Disease in HIV Mono-Infected Patients 110
Late HIV diagnosis - a tale of successes and failures 89
Distilling Clinical Scores with Symbolic Machine Learning: Frailty Index, an HIV Cohort Case Study 82
Prevalence and risk factors of cognitive frailty in people with HIV 73
Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65 Years 69
Association Between Reduced Daily Protein Intake and Sarcopenic Obesity in Men Living with HIV: A New Screening Tool 62
Health profiles of foreign-born elderly women with HIV in Italy 56
A Machine learning approach to predict Weight change in ART experienced PLWH 44
Introducing the WHO ICOPE approach into HIV care: A perspective on healthy ageing in people living with HIV 31
A multidisciplinary, AI‐supported quality improvement intervention to manage polypharmacy in aging people with HIV. 30
Cognitive and fine motor performance in people above 65 years of age with and without HIV 10
FIB-4 fails to identify significant liver fibrosis in people with HIV: A large multinational screening study 8
Reshaping long COVID care through patient-reported needs 4
Totale 14.067
Categoria #
all - tutte 55.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.303


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022963 86 46 58 64 52 92 37 50 102 98 171 107
2022/20231.831 158 227 195 153 194 158 117 177 167 39 140 106
2023/20241.251 70 99 79 154 170 131 92 110 49 56 98 143
2024/20252.647 84 65 69 194 469 389 180 141 358 165 224 309
2025/20265.201 371 234 356 585 757 363 633 248 477 459 380 338
2026/2027269 269 0 0 0 0 0 0 0 0 0 0 0
Totale 14.067